Management

Joshua [Shuki] Is a visionary founder and the driving force behind the Tzamal Medical Group. From a small company established back in 1972, Shuki has built Tzamal into a med-tech marketing powerhouse – fuelled by innovation and endless energy for growth. As its founder, Shuki is the driving force behind the company’s strategic planning and development. Shuki has gained over 45 years of life science marketing experience serving both healthcare multinational and domestic vendors

Assaf Katz heads the parent company, overseeing day-to-day operations. In addition, Assaf is heavily involved in searching for late-stage medical equipment start-up operation investments, of which have yielded numerous success stories, including Pulse Cath (cardiac assistance), Angioscore (cardiology) and Hernia Solutions (minimally invasive surgery). Assaf is a Business Administration graduate of the Interdisciplinary Center Herzliya

Eli Dadkha serves as Group’s Director of Finance overseeing the company’s Financial activities, and Information Technology. As the Group CFO, Eli applies his multidisciplinary expensive expertise for the benefit of the entire group operation. Prior to joining Tzamal, Eli Dadkha served as senior economist for several leading enterprises, including Visa Credit. Eli is an Israeli CPA

Co-founder of Tzamal Bio-Parma back in 2000, Mr. Steinberg brings along an academic – medical education as well as an extensive experience in the pharma business, as a former country Managing director of two leading pharmaceutical companies , inclusive a well-known multi-national.

Following few years of involvement in management functions , Osnat joined Tzamal Bio Pharma in 2014 .
Her first function was as a medical field representative, closely working with all KOL and major hospitals/institutes in the country. In 2017 she was appointed as the Director of Sales and Marketing, in charge of sales & marketing operations, negotiations with the local clients, contacts with the various business partners and involvement in companies’ B.D activities. In 2020 she was appointed as VP, Sales & Marketing . Since January 2022 Osnat is the CEO of Tzamal Bio Pharma, member of the Executive Management Board of the Group.

Sharon Menchel joined Tzamal Jakobsohn Ltd. in 2003 as a Sales Representative in the field of cardiology. Over the years, he has gained extensive experience in sales, marketing, and business development within the medical device industry, including the introduction and representation of leading global companies in the Israeli medical market.

In 2008, Sharon was appointed Manager of the Cardiovascular and Cardiac Surgery Division. In 2019, he was promoted to Deputy General Manager, leading the company’s commercial activities across a broad range of medical fields, including cardiovascular and cardiac surgery, general surgery, general instruments, ophthalmology, and dermatology.

Since 2025, Sharon serves as General Manager of Tzamal Jakobsohn Ltd., leading the company’s strategic growth, business operations, and continued expansion in the Israeli healthcare market while strengthening partnerships with global medical technology companies.

Management

Joshua [Shuki] Katz

Assaf [Assi] Katz

Eli Dadkah

EDI STEINBERG

Mrs. Osnat Weisbord

SHARON MENCHEL